Breast cancer in Japanese men: Does sex affect prognosis?

被引：11

作者：

Anan K. ^{[1
]}

Mitsuyama S. ^{[1
]}

Nishihara K. ^{[1
]}

Abe Y. ^{[1
]}

Iwashita T. ^{[1
]}

Ihara T. ^{[1
]}

Tamae K. ^{[1
]}

Ono M. ^{[2
]}

Toyoshima S. ^{[3
]}

机构：

[1] Department of Surgery, Kitakyushu Municipal Medical Cente, Bashaku, Kitakyushu, Fukuoka 802-0077

[2] Department of Radiology, Kitakyushu Municipal Medical Cente

[3] Department of Pathology, Kitakyushu Municipal Medical Cente

来源：

Breast Cancer | 2004年 / 11卷 / 2期

关键词：

Asian; BRCA2; Ethnicity; Male;

D O I：

10.1007/BF02968299

中图分类号：

学科分类号：

摘要：

Background: Breast cancer has received much less investigative attention in Asian men than in Caucasian men. We examined whether the prognosis of Japanese men with breast cancer differs from that of Japanese women with the disease. Methods: The clinicopathological features of 14 Japanese men with breast cancer were reviewed and age-and stage-matched case-control analysis of these men and 140 female patients was performed. Results: Disease-free survival (p = 0.94) and overall survival (p = 0.62) did not differ significantly between the sexes. Five-year disease-free survival was 77% for the men and 75% for the women, and the 5-year overall survival was 92% for the men and 86% for the women. The disease recurred in 2 men but none died of breast cancer, although 3 died of other causes during the median follow-up period of 7 years. There were no significant differences in p53 mutation (p = 0.20) or erbB-2 oncoprotein overexpression (p = 0.33) between the men and women studied. Conclusion: Survival rates of Japanese male and female breast cancer patients are similar when age and stage of the disease are taken into consideration. However, comorbid disease mortality is likely the major contributor to clinical outcome in Japanese male breast cancer patients.

引用

页码：180 / 186

页数：6

共 29 条

[1]

Sasco A.J., Lowenfels A.B., Pasker-De Jong P., Review article: Epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors, International Journal of Cancer, 53, 4, pp. 538-549, (1993)

[2]

Ribeiro G.G., Carcinoma of the male breast: A review of 200 cases, British Journal of Surgery, 64, 6, pp. 381-383, (1977)

[3]

Heller K.S., Rosen P.P., Schottenfeld D., Male breast cancer: A clinicopathologic study of 97 cases, Annals of Surgery, 188, 1, pp. 60-65, (1978)

[4]

Norris H.J., Taylor H.B., Carcinoma of the male breast, Cancer, 23, pp. 1428-1435, (1969)

[5]

Goss P.E., Reid C., Pintilie M., Lim R., Miller N., Male breast carcinoma: A review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996, Cancer, 85, 3, pp. 629-639, (1999)

[6]

Cutuli B., Lacroze M., Dilhuydy J.M., Velten M., De Lafontan B., Marchal C., Resbeut M., Graic Y., Campana F., Moncho-Bernier V., De Gislain C., Tortochaux J., Cuillere J.C., Reme-Saumon M., N'Guyen T.D., Lesaunier F., Le Simple T., Gamelin E., Hery M., Berlie J., Male breast cancer: Results of the treatments and prognostic factors in 397 cases, European Journal of Cancer Part A: General Topics, 31, 12, pp. 1960-1964, (1995)

[7]

Donegan W.L., Redlich P.N., Lang P.J., Gall M.T., Carcinoma of the breast in males: A multiinstitutional survey, Cancer, 83, 3, pp. 498-509, (1998)

[8]

Brenner B., Fried G., Levitzki P., Rakowsky E., Lurie H., Idelevich E., Neuman A., Kaufman B., Sulkes J., Sulkes A., Male breast carcinoma in Israel: Higher incidence but possibly better prognosis in Ashkenazi Jews, Cancer, 94, 8, pp. 2128-2133, (2002)

[9]

O'Malley C.D., Prehn A.W., Shema S.J., Glaser S.L., Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma, Cancer, 94, 11, pp. 2836-2843, (2002)

[10]

Hsu J.L., Glaser S.L., West D.W., Racial/ethnic differences in breast cancer survival among San Francisco Bay Area women, Journal of the National Cancer Institute, 89, 17, pp. 1311-1312, (1997)

← 1 2 3 →